Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
Frontiers in Immunology
|
November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
Harjeet Singh, Samer A Srour, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched Analysis
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Journal of Attention Disorders
|
October 16, 2007
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome
Thomas J Spencer, F Randy Sallee, Donald L Gilbert, et al.
Leukemia & Lymphoma
|
June 26, 2026
D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience
Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology
|
July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Blood Cancer Journal
|
January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades
Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
Frontiers in Immunology
|
November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
Harjeet Singh, Samer A Srour, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched Analysis
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Journal of Attention Disorders
|
October 16, 2007
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome
Thomas J Spencer, F Randy Sallee, Donald L Gilbert, et al.
Leukemia & Lymphoma
|
June 26, 2026
D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience
Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology
|
July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Blood Cancer Journal
|
January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades
Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Page
of 19